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One of the central challenges to biology is understanding biological
information ﬂow such as how genotypes manifest into functional phe-
notypes. Historically, biological experiments have been difﬁcult to con-
duct leading to a scarcity of data. However, technological improvements
in experimental high-throughput measurements have shifted biology
to being a data-rich ﬁeld, driving a need for analytical tools to facilitate
the analysis and interpretation of biological data.
Metabolic engineering applies biological information to genetically
modify cellular function, usually toward production of a targeted chem-
ical or protein product. Metabolic engineering research requires knowl-
edge of integrated cellular function andmolecular detail to be successful.
Broadly, there are two types of approaches that lead to successful meta-
bolic engineering results: directed designs built upon knowledge orehalf of the Research Network of Co
0/).combinatorial screening that leverages high-throughput experimental
techniques. Within the past ﬁfteen years, computational tools have
been developed to leverage biological data in the analysis and design
of microbial strains for metabolic engineering and have facilitated
prospective metabolic engineering design. These tools began with
genome-scale metabolic models that aid in the analysis and prediction
of whole cell function and have expanded to include tools for predicting
the function of speciﬁc DNA sequences.
Here, a brief overview is presented on the development and progres-
sion of computational tools that can be applied tometabolic engineering.
Individual ﬁelds of systems biology, synthetic biology, computational
biology, or metabolic engineering are expansive enough for multiple
reviews. The speciﬁc focus of this mini-review is to focus on a subset of
tools from systems biology and synthetic biology that can be used in
combination to enable prospective in silico strain design. Key develop-
ments associated with genome-scale metabolic models and algorithms
that can be used to computationally propose microbial strain design
will be discussed. Speciﬁc developments in synthetic biology associatedmputational and Structural Biotechnology. This is an open access article under the CC
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placed within the context of genome-scale modeling and metabolic
engineering.
2. Main Text
Systems biology emphasizes data-intensive, integrative analyses
that account for extended network function. With the introduction of
whole genome sequencing and genomics technologies, one of the ﬁrst
objectiveswas to developmethods utilizing genomic information to un-
derstand and predict phenotypic function. The constraint-basedmodel-
ing approach [1] was implemented to generate genome-scalemetabolic
models of some of the ﬁrst organisms with genome sequences [2–4],
demonstrating the conceptual value of this computational approach.
The initial genome-scale models were constructed based upon genomic
data (sequence information) and biochemical data (reaction stoichiom-
etry) in conjunction with linear programming to apply mass balancing
principles to a whole-cell system. The conceptual framework provided
a context for analyzing attributes of a cellular system [5] and was
shown to be able to predict cellular growth phenotypes [6,7].
Since the initial development of genome-scale models, a wide variety
of improvements have beenmade to address different needs. These range
from understanding the underlying structure of networks by using ele-
mentarymodes [8] or extreme pathways [9], model-building approaches
[10,11], and progressivelymore cellular detail including thermodynamics
[12], transcriptional regulation [13,14], and signaling pathways [15]. All of
these have contributed to improve the predictive capability and accuracy
of genome-scale metabolic models and can be used to study a variety of
aspects of cellular systems. Here, we are speciﬁcally going to focus on
the existing tools and challenges associatedwith genome-scalemetabolic
models, particularly as they apply to metabolic engineering applications.
An overview of computational tools presented here is shown in Table 1,
which only represents a select subset of the numerous available tools
and algorithms that have been developed. A more comprehensive
(and continually updated) list of tools associated with constraint-based
models is curated online (cobramethods.wikidot.com).
2.1. Genome-scale Models and Metabolic Engineering
Using the natural ability of genome-scalemetabolic models to simu-
late the behavior of cellularmetabolism one can predict cellular designs
for maximizing chemical production. Metabolic engineering goals of
identifying and modifying pathway ﬂuxes to optimize the production
of a desired chemical product align well with the pathway-level predic-
tions that are generated from a genome-scalemodel. The foundation for
this work was demonstrated when it was shown that the constraint-
based modeling approach could reasonably predict the cellular growth
phenotypes resulting from genetic modiﬁcations (gene deletions) [16]Table 1
Overview of computational tools discussed.
Tool Description
OMNI Reconciles discrepancies between in silico an
MILP Reﬁned ﬂux state predictions based upon hig
E matrix Prediction of gene and protein expression lev
DFBA Dynamic ﬂux balance analysis
OptCom Multi-level optimization for modeling micro
d-OptCom Dynamic variant of OptCom
OptKnock Bi-level optimization for strain design using
EMILiO Strain design incorporating increased/decrea
CosMos Flux-based strain design
CASOP Strain design using elementary modes
FBrAtio Strain design based upon ﬂux ratios at critica
k-OptForce Strain design incorporating substrate-level in
DySScO Strain design incorporating process kinetics
PWM Prediction of DNA sequence variation on pro
RBS calculator Prediction of protein translation initiation rain Escherichia coli. This quickly led to a demonstration of using a
genome-scale model of E. coli to predict strain designs for the over-
production of lactic acid [17], which set the stage for genome-scale
models as powerful computational tools for strain design.
The ﬁrst iterations of combining computer-aided strain design with
experimental implementation relied on strain designs that incorporated
gene deletions. This approach was computationally achievable through
the removal of pathways associated with genes (following gene–pro-
tein–reaction relationships) and could be achieved experimentally
with established methods for targeted gene deletions using homolo-
gous recombination [18]. Initial results were promising from the stand-
point that the designs improved overall production of the desired
chemical, but there was still a quantitative mismatch between the com-
putationally calculated theoretical yield and the experimental yield.
The discrepancy between computationally predicted function
and actual function led to the development of an algorithm to predict
targets for iterative improvement of the experimental strain [19]. By
utilizing transcriptomic data of the experimental strain, algorithmic
analysis predicted areas of metabolism with the largest difference
between the theoretical and experimental function. This analysis pre-
dicted speciﬁc genes to be targeted for synthetic regulation of gene ex-
pression (increased or decreased expression). The problem remained in
connecting the computational prediction with tools for direct experi-
mental implementation. Recently, several developments have occurred
in parallel both computationally and experimentally.
For constraint-based genome-scale metabolic models, new method-
ologies and analyses continue to be developed that improve the accuracy
of these models to predict cellular phenotypes. One major consideration
for genome-scale metabolic models is that themathematical representa-
tion for a biological system is underdetermined and thus, the same cellu-
lar phenotype can be reproduced from different underlying ﬂux states/
pathway usage. This problem complicates metabolic engineering design.
For example, a normal growth phenotypemay have numerous proposed
ﬂux states that vary in speciﬁc pathway use, but produce the same cellu-
lar growth rate/product yield. However, once genetic modiﬁcation of the
network is implemented, all of the possible ﬂux states may no longer be
functionally equivalent. When considering growth phenotypes at the
level of cellular growth, it may not be necessary to explicitly identify
the exact ﬂux state of the cell. Knowledge of the starting in vivo ﬂux
state is important for pathway-speciﬁc metabolic engineering design.
The problem of identifying in vivo ﬂux states within the context of
genome-scale metabolic models has been approached using a combina-
tion of high-throughput experimental data and computational algo-
rithms. The initial formulation of this approach used transcriptomic
or proteomic data with a human metabolic model to identify tissue-
speciﬁc metabolic differences [20]. In this approach, the experimental
data was translated to a binary present/absent scoring for each individual
transcript/protein. The scored experimental datawas thenalgorithmicallyReference
d in vivo phenotypes using transcriptomics [19]
h-throughput experimental data [20]
els [25]
[27]
bial consortia [30]
[31]
gene deletions [32]
sed gene expression [37]
[38]
[39]
l nodes [40]
hibition [41]
[42]
moter strength [48]
tes [50]
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ear programming (MILP) to calculate a ﬂux state that is parsimonious
with the experimental data. The underlying principle seeks to maximize
the agreement between experimental data and computational ﬂuxes
where experimentally present entities can carry ﬂux and experimentally
absent entities should have zero ﬂux.
The MILP approach to experimental data integration and prediction
of in vivo ﬂux states has started to be adopted for metabolic engineering
purposes. One example of this is the development and analysis of a met-
abolic model for the cellulolytic anaerobe, Clostridium thermocellum.
C. thermocellum naturally produces a cellulosome that efﬁciently breaks
down cellulosic biomass in carbohydratemonomers that C. thermocellum
can ferment into ethanol and hydrogen as metabolic end-products.
Thus, C. thermocellum has been a focal organism for biofuel development.
After developing a C. thermocellum model that explicitly produces
a cellulosome [21], RNA sequencing (RNAseq) data was obtained to
study the transcriptome. MILP integration of the RNAseq data with the
metabolic model helped improve the accuracy of computational predic-
tions and helped identify genetic targets to improve biofuel production
[22].
Another major improvement in genome-scale metabolic modeling
was the explicit inclusion of charge-balancing for biochemical reactions.
While the initial formulation of constraint-basedmodelswas based upon
material balances, reactions were not necessarily charge-balanced with-
out careful curation of individual reactions. This was ﬁrst implemented
with the model for E. coli [23] and has become standard practice for
constraint-based model reconstruction. This detailed aspect of the
models becomes integral to metabolic engineering especially in cases
involving fermentationwhere restricted energetics lead to higher ﬂuxes
and distributions of metabolic end-products need to maintain redox
balance for the cell. This was shown to be particularly important for or-
ganisms with growth phase shifts such as the commercial organism
Clostridium acetobutylicum that is central to the acetone–butanol–etha-
nol process. C. acetobutylicum goes through distinct acidogenic and
solventogenic growth phases with widely different metabolic end-
products produced in each phase. Critical to understanding and model-
ing the shift and difference in end-products producedwas the develop-
ment and analysis of proton ﬂuxes for C. acetobutylicum [24].
One of themost recentmajor conceptual advances in the constraint-
based modeling methodology was the formulation of the Expression
matrix, or E matrix, in E. coli [25,26]. Constraint-based models to this
point have been developed using biochemical reaction stoichiometry
to form a stoichiometric matrix (S) that provides and establishes a
gene–protein–reaction (GPR) relationship for metabolic functions. The
stoichiometric matrix provides the basis for all simulations utilizing
ﬂux balance analysis (FBA), but considers the metabolic network as an
abstraction from the cell where basically any gene product can be pro-
duced at any amount with no cellular cost. The E matrix represents a
major advancement in detail and prediction as it explicitly accounts
for all mechanisms required for transcription, translation, andmodiﬁca-
tion of each gene product. Alongwith adding a new level of mechanistic
biological detail, the development of the Ematrix enables the prediction
of two important aspects of cellular function. One is that the Ematrix al-
lows a priori prediction of the transcriptome and proteome directly
based upon a genetic sequence. The secondmajor beneﬁt is that cellular
costs can be associated with producing each gene product, thus the cel-
lular cost–beneﬁt aspect of expressing pathways (e.g. heterologous
pathways) can now be considered.
Based upon the stoichiometric matrix (or even including the expres-
sion matrix), standard simulations using genome-scale metabolic
models utilize ﬂux balance analysis (FBA) as a staple for making predic-
tions of pathway ﬂuxes and phenotypes. This analysis assumes a
pseudo-steady state hypothesis and does not explicitly account for any
process kinetics. A methodological improvement to FBA was the devel-
opment of dynamic ﬂux balance analysis (DFBA) [27]. DFBAwas initially
developed considering two different approaches to explicitly integratekinetics into FBA simulations. The ﬁrst approach was to reformulate
the problem to account for metabolite concentrations and the dynamic
optimization problems were solved using non-linear programming
over the entire designated time period of interest. The second approach
discretized the time period of interest into smaller time steps that were
solved individually using linear programmingwith a ﬁnal integration of
time steps. Both approaches extended the analytical capabilities of the
E. colimodel when used to study diauxic growth on glucose [27].
The concept of DFBA has been expanded to also explicitly include
Michaelis–Menten kinetics for processes where reasonable rate param-
eters could be found and used as a basis for modelingmicrobial consor-
tia. Designer microbial consortia are gaining interest as a potential
means of efﬁciently utilizing some of the unique capabilities of different
microbes. In the cellulosic bioreﬁnery for example, since many of the
highly efﬁcient cellulolytic microbes are strict anaerobes and have
poor tools for genetic manipulation the process consists of two steps:
sacchariﬁcation by a cellulolytic microbe and fermentation of freed
sugars to a metabolic product by a genetically tractable microbe. Thus,
a single-step consolidated bioprocess (CBP) could conceptually be
designed from a microbial consortium with an anaerobic cellulolytic
microorganism for the degradation of lignocellulosic material, a
supporting facultative anaerobe that can be used to consume oxygen
to produce an anaerobic environment and cross-feed off of secreted
metabolic end-products to produce a desired chemical product.
Microbial consortia are often difﬁcult to propagate and stabilize
in a laboratory setting making experimental approaches to consor-
tium design difﬁcult. Ideally, genome-scale metabolic models can
be used to study and predict microbial consortium behavior. While
themass balance conceptual framework of metabolic inputs and out-
puts is foundational to computational study of microbial consortia,
analytical frameworks needed to be developed to interface individual
organism models. To date, there have been two noted formulations
of constraint-based modeling approaches applied to microbial consor-
tia. The ﬁrst was an iteration of DFBA that modeled a co-culture of
C. acetobutylicum and Clostridium cellulolyticum [28]. This formulation
was used as a basis for studying some of the interactions between the
two Clostridia to elucidate some of the synergies that arise from co-
culture [29]. Independently, a separate multi-level optimization com-
putational framework known as OptCom was developed as a general
and scalablemeans of studyingmicrobial communities and the interac-
tionswithin those communities [30]. The OptCom framework considers
the community by splitting optimization between individual organism
ﬁtness considerations and the overall community ﬁtness as a secondary
optimization. The OptCom framework was later expanded to explicitly
incorporate dynamic behavior in the d-OptCom framework [31].
The d-OptCom framework was initially used to study auxotrophic
strains of E. coli and a microbial community composed of Geobacter
sulfurreducens, Rhodoferax ferrireducens, and Shewanella oneidensis that
reduce uranium [31].
The ﬁnal analytical component when using genome-scale metabolic
models as a tool for microbial strain design is an algorithm that can
facilitate the design process. A growing number of algorithms have
been developed that expand the predictive capabilities of genome-
scale models to simulate different strain design parameters. One of the
ﬁrst strain design algorithms to be developed for use with genome-
scale metabolic models was OptKnock [32] that formulated a bi-level
optimizationwhere gene deletionswere considered to increase the pro-
duction of a desired chemicalwhilemaintaining cellular growth. Under-
lying the algorithm development was the premise that secretion of a
target chemical could be stoichiometrically coupled to growth such
that the faster a cell grew the faster the chemical would be produced.
E. coli strains designed byOptKnock to secrete lactic acid experimentally
demonstrated that it is possible to couple growth with chemical secre-
tion. Subsequent to OptKnock, several variant algorithms have been
developed including OptStrain [33], OptORF [34], OptFlux [35], and
OptForce [36].
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have been numerous variant algorithms developed to address computa-
tional or algorithmic limitations. EMILiO [37] was developed as a com-
putationally efﬁcient algorithm for searching through a broader range
of possible genetic manipulations. CosMos [38] developed designs for
a variety of manipulations, but considered the problem based upon
ﬂuxes (and ﬂux modiﬁcations). Elementary modes were used as the
design basis for identifying knockout or overexpression targets in the
CASOP [39] method and relative ﬂux ratios were used as a design crite-
rion for FBrAtio [40]. The recent algorithms such as k-OptForce [41]
and DySScO [42] have incorporated process kinetics into the design
consideration.
Using any of these approaches allows the prediction of how ge-
netic modiﬁcation will impact an organism production of a target
chemical. These predictions even provide sufﬁcient detail to identify
on a pathway-by-pathway basis the exact ﬂux that is required to
achieve the optimal production rate. The challenge has remained in
the translation of the computationally predicted strain design (and cor-
responding optimal ﬂux state) to the in vivo system. In other words, if
you can identify exactly what pathways youwant to express and exact-
ly what ﬂux you want through each of those pathways, how do you get
your cell to exactly match the computational prediction?2.2. Synthetic Biology
Experimentally, the rapid development ofmolecular biology and ge-
netic engineering tools typiﬁed by synthetic biology has signiﬁcantly in-
creased the ability to explicitly design and implement controllable
genetic constructs. These improvements were enabled by the techno-
logical advances in DNA synthesis and rapid, high-ﬁdelity assembly of
DNA fragments [43–45]. Once genetic circuits could be constructed in
an efﬁcient and inexpensive manner with base-by-base speciﬁcity, it
was possible to interrogate sequence-to-function relationships. While
central to the investigation of all biological functions, for metabolic en-
gineering applications this represented a broad advance where ﬁner
control over the expression of genes in a given pathway could be de-
signed and implemented. Designed expression control for individual
genes typically occurs either at the transcription or translation levels.
Developments in synthetic biology have occurred in parallel withFig. 1. Timeline showing several major developments in synthetic biology ansystems biology developments (Fig. 1) and enable multi-scale ap-
proaches to metabolic engineering.
2.3. Transcription
The ﬁrst level of functional control for speciﬁc genes occurs during
transcription. The transcriptional process involves a binding event be-
tween a DNA sequence (promoter) and RNA polymerase to initiate poly-
merization of an mRNA. When naturally occurring promoter sequences
are analyzed, there are conserved sequence motifs corresponding to re-
gions that physically bind to the sigma subunit of the RNA polymerase.
Sequence variation in the promoter affects transcriptional strength;
however, it has been difﬁcult to predict the binding interaction between
a promoter and RNApolymerase as it involves binding betweenDNAand
a folded protein.
Some of the early work in this areawas empirically based (out of ne-
cessity). Naturally occurring variations in DNA sequences associated
with transcription were identiﬁed and characterized in terms of tran-
scriptional effect (strength). Identiﬁcation of these DNA sequences was
the basis for constructing and characterizing libraries of transcription-
associated DNA sequences. In the early stages of the development
of synthetic biology and the Registry of Standard Biological Parts
(parts.igem.org), transcriptional DNA parts were created and cataloged
allowing for more detailed characterization and use of genetic variants
for transcriptional control [46].
The decreased cost of direct DNA synthesis further expedited the in-
vestigation of sequence variation to function for transcriptional control.
Base-by-base changes in promoter (or UP element) sequences could be
accurately synthesized and rapidly tested in synthetic DNA constructs.
Controlled sequence-to-function relationships could then be extrapo-
lated usingmathematical correlationmethods such as a positionweight
matrix (PWM).
PWMs are a mathematical representation of a pattern and were
initially applied to biological systems as a quantitative means of investi-
gating conserved DNA sequences [47]. Recently, PWMs have been used
to quantitatively describe the sequence-to-function relationship for
promoters in E. coli [48]. By dividing promoter sequences into 6 motifs
(−35, spacer,−10, disc start, initial transcribed region), 60 different
promoter sequences were characterized for promoter strength and used
to evaluate the inﬂuence of speciﬁc genetic changes on function [48].d systems biology of signiﬁcance to metabolic engineering applications.
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sequences called UP elements [49], which occur upstream of core pro-
moter sequences. In these cases, PWMs were used to mathematically
model the relationship between sequence and function. Thus, with the
recent modeling developments, transcriptional control has progressed
from empirical understanding to quantitatively modeled predictions
that can direct synthetic promoter design to produce a desired level of
transcriptional strength.
2.4. Translation
Following transcription, mRNA is translated into proteins. Transla-
tion initiates when a ribosome interacts with a ribosome binding site
(RBS) and facilitates the subsequent tRNA binding to mRNA codons to
produce polypeptides by the addition of amino acids. Translation
involves three steps: Initiation, elongation, and termination. Of these
three steps, translation initiation is the rate-limiting step and within
each cell different rates of translation initiation are found due to varia-
tion in theDNA sequence of theRBS. Thus, the functional amount of pro-
tein produced in terms of translation is tied to the thermodynamics of
RBS–ribosome interaction.
Recently, a computational approach has been developed to predict
translation initiation rates for all start codons in a given DNA sequence
based upon a thermodynamic calculation of Gibbs free energy [50,51].
This calculation speciﬁcally considers the interaction of the 30S ribo-
somal subunit with a speciﬁc mRNA sequence. The total change in
Gibbs free energy (ΔGTot) is overall calculated as the difference in
Gibbs free energy between the 30S subunit complex bound to the
mRNA sequence and the 30S subunit and mRNA sequence with no in-
teraction. This “Ribosome Binding Site Calculator” [50] can be used not
only to predict translation initiation rates for existing sequences, but
also to design de novo RBS sequences for synthetically controlling trans-
lated protein levels.
Synthetic biology has nowdeveloped a complement of experimental
and computational tools to design and control individual gene expres-
sion levels at both the transcriptional and translational levels [52].Fig. 2. Schematic depiction of multi-scale biological processesThese tools enable a ﬁner level of design control for biological systems
and can be implemented for metabolic engineering applications
where the production of a desired product is typically linked to carefully
balancingmultiple pathway ﬂuxes. Progress in synthetic biology is pro-
viding a suite of molecular-level tools that is a natural complement to
network/systems-level analyses.
3. Summary and Outlook
As a ﬁeld, metabolic engineering leverages the vast diversity of bio-
chemical capabilities found in biological systems to produce a desired
product. Successful metabolic engineering projects typically balance
systems-level strain design and molecular-level detail to modify cell
function. As such, metabolic engineering projects often incorporate
the most recent biological knowledge and tools as these projects span
all levels of biological organization and function within a cell. Due to
the complexity andmulti-scale nature of cellular systems computation-
al modeling methods are instrumental for analyzing and predicting
function, Fig. 2.
For system-level design, genome-scale metabolic models have de-
veloped into a robust computational tool for predicting consequences
of network modiﬁcations on cellular function. Building upon the stoi-
chiometric foundation underlying genome-scale metabolic models, nu-
merous improvements have beenmade in terms of model contents and
analytical tools. It is nowpossible to computationally simulate themajor
cellular components starting with a genome through mechanistic ex-
pression and function of proteins. These simulations can be used for
prospective computational design of microbial strains with modiﬁed
function.
Depending upon the speciﬁc strain design, experimental implemen-
tation can involve the combinations of gene deletions, gene additions
(heterologous expression), gene knockdown, or gene over-expression.
At a molecular-level, it becomes important to understand how best to
achieve the desired gene construct and how to experimentally imple-
ment the construct to achieve the desired expression level.Work in syn-
thetic biology has started to address both of these aspects through theand modeling approaches used to analyze each process.
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constructs and speciﬁc tools for transcription and translation. These
molecular-level tools allow DNA sequences to be designed to provide
desired levels of transcription and translation to achieve desired levels
of protein function. Furthermore, the designed sequences can then be
directly implemented experimentally using DNA synthesis and assem-
bly methods.
Together, it is now possible to approach metabolic engineering pro-
jects usingmulti-scale computational modeling tools to direct all major
facets of experimental research. Metabolic network analysis and design
can be achieved using genome-scale models and optimization algo-
rithms. Speciﬁc desired pathway ﬂuxes predicted during network anal-
ysis can then be individually considered using molecular tools. Control
of transcription and translation of each individual gene can then be
designed and genetically encoded into a synthetic DNA construct for
implementation in an engineered microbial strain.
Progressively, the complexity of strain designs that can be imple-
mented will also increase opening avenues for targeting difﬁcult prod-
ucts or processes. Synthetic feedback loops or embedded biosensors
can be used as built-in control mechanisms for monitoring or triggering
cellular processes. Controlling the kinetics or throughput of upstream
and downstream pathways can minimize the effects of chemically
toxic intermediates. It may even be possible to completely redesign
[53] or refactor [54,55]) major components of metabolism to more efﬁ-
ciently utilize resource pools to minimize material drains going to bio-
mass. Undoubtedly, there will be a growing number of studies that
successfully incorporate and utilize systems biology and synthetic biol-
ogy such as the development of sequence-expression-activity maps
(SEAMAPs) [56] that help identify optimal sequences and expression
levels.
References
[1] Becker SA, Feist AM, MoML, Hannum G, Palsson BØ, et al. Quantitative prediction of
cellular metabolism with constraint-based models: the COBRA Toolbox. Nat Protoc
2007;2:727–38. http://dx.doi.org/10.1038/nprot.2007.99.
[2] Schilling CH, Covert MW, Famili I, Church GM, Edwards JS, et al. Genome-scale met-
abolic model of Helicobacter pylori 26695. J Bacteriol 2002;184:4582–93. http://dx.
doi.org/10.1128/JB.184.16.4582-4593.2002.
[3] SCHILLING CH, PALSSON BØ. Assessment of the metabolic capabilities of Haemophi-
lus inﬂuenzae Rd through a Genome-scale pathway analysis. J Theor Biol 2000;203:
249–83. http://dx.doi.org/10.1006/jtbi.2000.1088.
[4] Edwards JS, Palsson BO. The Escherichia coliMG1655 in silicometabolic genotype: its
deﬁnition, characteristics, and capabilities. Proc Natl Acad Sci 2000;97:5528–33.
http://dx.doi.org/10.1073/pnas.97.10.5528.
[5] Price ND, Reed JL, Palsson BØ. Genome-scale models of microbial cells: evaluating
the consequences of constraints. Nat Rev Microbiol 2004;2:886–97. http://dx.doi.
org/10.1038/nrmicro1023.
[6] Edwards JS, Ibarra RU, Palsson BO. In silico predictions of Escherichia coli metabolic
capabilities are consistent with experimental data. Nat Biotechnol 2001;19:
125–30. http://dx.doi.org/10.1038/84379.
[7] Fong SS, Marciniak JY, Palsson BØ. Description and interpretation of adaptive evolu-
tion of Escherichia coli K-12 MG1655 by using a genome-scale in silico metabolic
model. J Bacteriol 2003;185:6400–8. http://dx.doi.org/10.1128/JB.185.21.6400-
6408.2003.
[8] Trinh CT, Wlaschin A, Srienc F. Elementary mode analysis: a useful metabolic path-
way analysis tool for characterizing cellular metabolism. Appl Microbiol Biotechnol
2009;81:813–26. http://dx.doi.org/10.1007/s00253-008-1770-1.
[9] Price ND, Papin JA, Palsson BØ. Determination of redundancy and systems properties
of the metabolic network of Helicobacter pylori using genome-scale extreme path-
way analysis. Genome Res 2002;12:760–9. http://dx.doi.org/10.1101/gr.218002.
[10] Devoid S, Overbeek R, DeJonghM, Vonstein V, Best AA, et al. Automated genome an-
notation andmetabolic model reconstruction in the SEED andmodel SEED. In: Alper
HS, editor. Systems Metabolic Engineering. Methods in Molecular Biology. Humana
Press; 2013. p. 17–45 [Available: http://link.springer.com/protocol/10.1007/978-1-
62703-299-5_2. Accessed 29 May 2014.].
[11] Henry CS, DeJongh M, Best AA, Frybarger PM, Linsay B, et al. High-throughput gen-
eration, optimization and analysis of genome-scale metabolic models. Nat
Biotechnol 2010;28:977–82. http://dx.doi.org/10.1038/nbt.1672.
[12] BeardDA, Babson E, Curtis E, QianH. Thermodynamic constraints for biochemical net-
works. J Theor Biol 2004;228:327–33. http://dx.doi.org/10.1016/j.jtbi.2004.01.008.
[13] Covert MW, Palsson BØ. Transcriptional regulation in constraints-based metabolic
models of Escherichia coli. J Biol Chem 2002;277:28058–64.
[14] COVERT MW, SCHILLING CH, PALSSON B. Regulation of gene expression in ﬂux bal-
ancemodels of metabolism. J Theor Biol 2001;213:73–88. http://dx.doi.org/10.1006/
jtbi.2001.2405.[15] Papin JA, Palsson BO. The JAK-STAT signaling network in the human B-cell: an ex-
treme signaling pathway analysis. Biophys J 2004;87:37–46. http://dx.doi.org/10.
1529/biophysj.103.029884.
[16] Fong SS, Palsson BØ. Metabolic gene-deletion strains of Escherichia coli evolve
to computationally predicted growth phenotypes. Nat Genet 2004;36:1056–8.
http://dx.doi.org/10.1038/ng1432.
[17] Fong SS, Burgard AP, Herring CD, Knight EM, Blattner FR, et al. In silico design and
adaptive evolution of Escherichia coli for production of lactic acid. Biotechnol Bioeng
2005;91:643–8. http://dx.doi.org/10.1002/bit.20542.
[18] Datsenko KA,Wanner BL. One-step inactivation of chromosomal genes in Escherichia
coli K-12 using PCR products. Proc Natl Acad Sci 2000;97:6640–5. http://dx.doi.org/
10.1073/pnas.120163297.
[19] Herrgård MJ, Fong SS, Palsson BØ. Identiﬁcation of genome-scale metabolic network
models using experimentally measured ﬂux proﬁles. PLoS Comput Biol 2006;2:e72.
http://dx.doi.org/10.1371/journal.pcbi.0020072.
[20] Shlomi T, Cabili MN, Herrgård MJ, Palsson BØ, Ruppin E. Network-based prediction
of human tissue-speciﬁc metabolism. Nat Biotechnol 2008;26:1003–10. http://dx.
doi.org/10.1038/nbt.1487.
[21] Roberts SB, Gowen CM, Brooks JP, Fong SS. Genome-scale metabolic analysis of
Clostridium thermocellum for bioethanol production. BMC Syst Biol 2010;4:31.
http://dx.doi.org/10.1186/1752-0509-4-31.
[22] Gowen CM, Fong SS. Genome-scalemetabolic model integratedwith RNAseq data to
identify metabolic states of Clostridium thermocellum. Biotechnol J 2010;5:759–67.
http://dx.doi.org/10.1002/biot.201000084.
[23] Reed JL, Vo TD, Schilling CH, Palsson BO. An expanded genome-scale model of
Escherichia coli K-12 (iJR904 GSM/GPR). Genome Biol 2003;4:R54. http://dx.doi.
org/10.1186/gb-2003-4-9-r54.
[24] Senger RS, Papoutsakis ET. Genome-scale model for Clostridium acetobutylicum:
part II. Development of speciﬁc proton ﬂux states and numerically determined
sub-systems. Biotechnol Bioeng 2008;101:1053–71. http://dx.doi.org/10.1002/bit.
22009.
[25] Thiele I, Fleming RMT, Que R, Bordbar A, Diep D, et al. Multiscalemodeling ofmetab-
olism and macromolecular synthesis in E. coli and its application to the evolution of
codon usage. PLoS One 2012;7:e45635.
[26] Thiele I, Jamshidi N, Fleming RMT, Palsson BØ. Genome-scale reconstruction of
Escherichia coli's transcriptional and translational machinery: a knowledge base, its
mathematical formulation, and its functional characterization. PLoS Comput Biol
2009;5:e1000312. http://dx.doi.org/10.1371/journal.pcbi.1000312.
[27] Mahadevan R, Edwards JS, Doyle III FJ. Dynamic ﬂux balance analysis of diauxic
growth in Escherichia coli. Biophys J 2002;83:1331–40. http://dx.doi.org/10.1016/
S0006-3495(02)73903-9.
[28] Salimi F, Zhuang K, Mahadevan R. Genome-scale metabolic modeling of a clostridial
co-culture for consolidated bioprocessing. Biotechnol J 2010;5:726–38. http://dx.
doi.org/10.1002/biot.201000159.
[29] Mahadevan R, Henson MA. Genome-based modeling and design of metabolic inter-
actions in microbial communities. Comput Struct Biotechnol J 2012;3:e201210008.
http://dx.doi.org/10.5936/csbj.201210008.
[30] Zomorrodi AR, Maranas CD. OptCom: a multi-level optimization framework for the
metabolic modeling and analysis of microbial communities. PLoS Comput Biol
2012;8:e1002363. http://dx.doi.org/10.1371/journal.pcbi.1002363.
[31] Zomorrodi AR, Islam MM, Maranas CD. d-OptCom: dynamic multi-level and multi-
objective metabolic modeling of microbial communities. ACS Synth Biol 2014;3:
247–57. http://dx.doi.org/10.1021/sb4001307.
[32] Burgard AP, Pharkya P, Maranas CD. Optknock: a bilevel programming framework
for identifying gene knockout strategies for microbial strain optimization.
Biotechnol Bioeng 2003;84:647–57. http://dx.doi.org/10.1002/bit.10803.
[33] Pharkya P, Burgard AP, Maranas CD. OptStrain: a computational framework for rede-
sign of microbial production systems. Genome Res 2004;14:2367–76. http://dx.doi.
org/10.1101/gr.2872004.
[34] Kim J, Reed JL. OptORF: optimal metabolic and regulatory perturbations for metabol-
ic engineering of microbial strains. BMC Syst Biol 2010;4:53. http://dx.doi.org/10.
1186/1752-0509-4-53.
[35] Rocha I, Maia P, Evangelista P, Vilaça P, Soares S, et al. OptFlux: an open-source
software platform for in silico metabolic engineering. BMC Syst Biol 2010;4:45.
http://dx.doi.org/10.1186/1752-0509-4-45.
[36] Ranganathan S, Suthers PF, Maranas CD. OptForce: an optimization procedure for
identifying all genetic manipulations leading to targeted overproductions. PLoS
Comput Biol 2010;6:e1000744. http://dx.doi.org/10.1371/journal.pcbi.1000744.
[37] Yang L, Cluett WR, Mahadevan R. EMILiO: a fast algorithm for genome-scale
strain design. Metab Eng 2011;13:272–81. http://dx.doi.org/10.1016/j.ymben.2011.
03.002.
[38] Cotten C, Reed JL. Constraint-based strain design using continuous modiﬁcations
(CosMos) of ﬂux bounds ﬁnds new strategies for metabolic engineering. Biotechnol
J 2013;8:595–604. http://dx.doi.org/10.1002/biot.201200316.
[39] Hädicke O, Klamt S. CASOP: a computational approach for strain optimization
aiming at high productivity. J Biotechnol 2010;147:88–101. http://dx.doi.org/10.
1016/j.jbiotec.2010.03.006.
[40] McAnulty MJ, Yen JY, Freedman BG, Senger RS. Genome-scale modeling using ﬂux
ratio constraints to enable metabolic engineering of clostridial metabolism in silico.
BMC Syst Biol 2012;6:42. http://dx.doi.org/10.1186/1752-0509-6-42.
[41] Chowdhury A, Zomorrodi AR, Maranas CD. k-OptForce: integrating kinetics with ﬂux
balance analysis for strain design. PLoS Comput Biol 2014;10:e1003487. http://dx.
doi.org/10.1371/journal.pcbi.1003487.
[42] Zhuang K, Yang L, Cluett WR, Mahadevan R. Dynamic strain scanning optimization:
an efﬁcient strain design strategy for balanced yield, titer, and productivity. DySScO
strategy for strain design. BMC Biotechnol 2013;13:8.
34 S.S. Fong / Computational and Structural Biotechnology Journal 11 (2014) 28–34[43] Gibson DG, Young L, Chuang R-Y, Venter JC, Hutchison 3rd CA, et al. Enzymatic as-
sembly of DNA molecules up to several hundred kilobases. Nat Methods 2009;6:
343–5. http://dx.doi.org/10.1038/nmeth.1318.
[44] Sleight SC, Sauro HM. BioBrick™ assembly using the in-fusion PCR cloning kit.
Methods Mol Biol 2013;1073:19–30. http://dx.doi.org/10.1007/978-1-62703-625-
2_3.
[45] Annaluru N, Muller H, Mitchell LA, Ramalingam S, Stracquadanio G, et al. Total syn-
thesis of a functional designer eukaryotic chromosome. Science 2014;344:55–8.
http://dx.doi.org/10.1126/science.1249252.
[46] Kelly JR, Rubin AJ, Davis JH, Ajo-Franklin CM, Cumbers J, et al. Measuring the activity
of BioBrick promoters using an in vivo reference standard. J Biol Eng 2009;3:4.
http://dx.doi.org/10.1186/1754-1611-3-4.
[47] Stormo GD, Schneider TD, Gold L, Ehrenfeucht A. Use of the “Perceptron” algorithm
to distinguish translational initiation sites in E. coli. Nucleic Acids Res 1982;10:
2997–3011.
[48] Rhodius VA, Mutalik VK. Predicting strength and function for promoters of the
Escherichia coli alternative sigma factor, sigmaE. Proc Natl Acad Sci U S A 2010;
107:2854–9. http://dx.doi.org/10.1073/pnas.0915066107.
[49] Rhodius VA, Mutalik VK, Gross CA. Predicting the strength of UP-elements and full-
length E. coli σE promoters. Nucleic Acids Res 2012;40:2907–24. http://dx.doi.org/
10.1093/nar/gkr1190.[50] Salis HM. Chapter two — the ribosome binding site calculator. In: Voigt
Christopher, editor. Methods in Enzymology. Synthetic Biology, Part B Computer
Aided Design and DNA Assembly. Academic Press; 2011. p. 19–42 [Available:
http://www.sciencedirect.com/science/article/pii/B9780123851208000024.
Accessed 29 May 2014].
[51] Salis HM, Mirsky EA, Voigt CA. Automated design of synthetic ribosome binding sites
to control protein expression. Nat Biotechnol 2009;27:946–50. http://dx.doi.org/10.
1038/nbt.1568.
[52] Mutalik VK, Guimaraes JC, Cambray G, Lam C, Christoffersen MJ, et al. Precise and re-
liable gene expression via standard transcription and translation initiation elements.
Nat Methods 2013;10:354–60. http://dx.doi.org/10.1038/nmeth.2404.
[53] Bogorad IW, Lin T-S, Liao JC. Synthetic non-oxidative glycolysis enables complete car-
bon conservation. Nature 2013;502:693–7. http://dx.doi.org/10.1038/nature12575.
[54] Temme K, Zhao D, Voigt CA. Refactoring the nitrogen ﬁxation gene cluster from
Klebsiella oxytoca. Proc Natl Acad Sci U S A 2012;109:7085–90. http://dx.doi.org/
10.1073/pnas.1120788109.
[55] Chan LY, Kosuri S, Endy D. Refactoring bacteriophage T7. Mol Syst Biol 2005;1.
http://dx.doi.org/10.1038/msb4100025 [2005.0018].
[56] Farasat I, Kushwaha M, Collens J, Easterbrook M, Guido M, et al. Efﬁcient search,
mapping, and optimization of multi-protein genetic systems in diverse bacteria.
Mol Syst Biol 2014;10:731.
